4.4 Article

The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison

Amir Hossein Behnoush et al.

Summary: This article compares the guidelines from the 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) and the 2021 European Society of Cardiology (ESC) for the diagnosis and treatment of heart failure (HF), highlighting the differences and latest evidence in each. Both guidelines recommend invasive and non-invasive tests for diagnosis, but there are differences in medical therapy and devices. The ACC/AHA/HFSA guidelines emphasize quality of life, cost-effectiveness, and optimization of care, while the ESC guidelines provide recommendations for specific comorbidities.

ESC HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Paul A. Heidenreich et al.

Summary: This article provides an overview of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, including its aim, methods, and structure.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Review Medicine, General & Internal

Dilated cardiomyopathy: from epidemiologic to genetic phenotypes A translational review of current literature

D. Reichart et al.

JOURNAL OF INTERNAL MEDICINE (2019)

Article Medicine, General & Internal

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Lars Kober et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials

Muaamar Al-Gobari et al.

BMC CARDIOVASCULAR DISORDERS (2013)

Article Medicine, General & Internal

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis

Saurav Chatterjee et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Article Medicine, General & Internal

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

GH Bardy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy

A Kadish et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

AJ Moss et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)